Key Takeaways
- • Angelini Ventures, BioGeneration Ventures (BGV), Kurma Partners and the European Investment Bank (EIB) co-led a $58 million Series A round in Dutch biotech RougeTx to fund development of drug RTX-001.
- • London fintech TrueLayer raised $27 million from lead investor CDP Venture Capital, bringing its total funding since 2016 founding to $349 million.
- • Dialybrid closed a €15 million Series A led by XGEN Venture, with participation from CDP Venture Capital.
- • LimoLane, a Cherry Bay Capital Group portfolio company, acquired French firm Evendis.
- • NVM Ventures raised €23.6 million for NVM Venture Lazio against a €35 million target.
Summary
London-based fintech TrueLayer, founded in 2016 by CEO Francesco Simoneschi and CTO Luca Martinetti, raised $27 million from lead investor CDP Venture Capital and other investors. BeBeez reports that the company has raised $349 million since its founding. Mario Branciforti heads the Large Venture fund at CDP Venture Capital. Prior backers include Northzone, Tencent, Tiger Global, Temasek and Stripe.
Dialybrid, a company formed in August 2020 through a partnership between founder, chairman and CEO Francesco Greco and LIFTT, secured a €15 million Series A round led by XGEN Venture, with CDP Venture Capital also participating. A&O Shearman advised on the deal, and Sani Zangrando Studio Legale Associato advised the company. Delta Med, a portfolio company of White Bridge Investments and Augens Capital, holds 77% of BEL, while Greco owns 23%.
SimpL raised a €1.2 million pre-seed round led by Techshop Capital, with Vento Ventures – Exor and business angels participating. Zest completed its exit from Epic Holding for €0.863 million, with a 16% IRR and 3.5x return on investment. LimoLane, a Cherry Bay Capital Group portfolio company founded by Fabio Nalucci, acquired French firm Evendis from its founders. NVM Ventures, a Luxembourg-based vehicle, raised €23.6 million for NVM Venture Lazio, short of its €35 million target. NATAM Management Company, a Banca Finnat subsidiary, will administer the fund.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.